Dec 9, 2020
This episode focuses on the clinical aspects of endocarditis you
can catch in the exam room, emphasizing the joint and skin
manifestations, along with some interesting historical insights on
Osler nodes and Janeway lesions.
Brought to you by GSK. Considering a treatment change for
patients with active SLE? Learn about a treatment option for your
patients at treatfortodayandtomorrow.com.
- Intro :11
- In this episode :22
- About episode two 2:28
- Rheumatologic manifestations of infectious endocarditis
- Musculoskeletal manifestations of infectious endocarditis in
the back 5:55
- The lack of patterns for infectious endocarditis causing joint
- Myalgias and the connection with endocarditis
- The skin and its connection with endocarditis
- What are Janeway lesions 17:13
- What are Osler nodes? 19:28
Brought to you by GSK. Consider the long-term impact of
disease activity flares and corticosteroid use on patients with
active SLE. Learn more now at
- What causes these lesions? 21:24
- Differentiating Osler’s nodes and Janeway lesions
- What are splinter hemorrhages?
- Petechiae and its association to infective endocarditis
- What about leukocytic vasculitis?
- Other puzzle pieces to look for
- A preview of next episode 40:30
- Conclusion 42:12
Disclosure: Brown reports no relevant financial
We’d love to hear from you! Send your comments/questions to Dr.
Brown at firstname.lastname@example.org.
Follow us on Twitter @HRheuminations @AdamJBrownMD @HealioRheum
Chahoud J, et al. Cardiol Rev. 2016;24:230-7.
JB, Silverman ME. Chest. 1976;70:239-43.
Godeau P, et al. Rev Med Interne. 1981;2:29-32.
Gunson TH, Oliver GF. Australas J Dermatol.
West J Med. 1979;131:85-91.
Loricera J, et al. Clin Exp Rheumatol.
M, et al. Am J Med. 2014;S0002-9343(14)00188-0.
O, et al. Infection. 2018;46.
Commerford PJ. Ann of the Rheum Dis.
et al. J Am Acad Dermatol. 1996;35:767-8.
Young J. et
al. J R Coll Physicians Lond. 1988;22:240-3.